TrialBritish journal of clinical pharmacology2025

Pharmacokinetics, pharmacodynamics and safety of casdatifan, a novel hypoxia-inducible factor-2α inhibitor, in healthy participants.

Mohammad Ghasemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.